NMD PHARMA NEUROMUSCULAR DISORDERS
Live / Applied — Non-final action mailed (as of 18 Jan 2026)
What this means for you
Not registered yet, but its 15 Jul 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79432114
- Mark type
- Design + words
- Filed
- 15 Jul 2025
- Attorney of record
- Julie A. Greenberg
Goods and services
- Class 005 — Pharmaceuticals: Preparations for pharmaceutical purposes, preparations for medical purposes, chemical-pharmaceutical preparations, diagnostic preparations for medical purposes, reagents for medical purposes, preparations for analysis for medical purposes; pharmaceutical and medical preparations for the treatment of rare and genetic diseases; pharmaceutical and medical preparations for the treatment of neurodegenerative diseases; pharmaceutical and medical preparations for the treatment of neuromuscular disorders; pharmaceutical and medical preparations that strengthen neuromuscular transmission and muscle function in patients with neuromuscular disorders, pharmaceutical and medical preparations for acute hospital care
- Class 042 — Scientific and technological services: Scientific and technological services and research, namely, research in the field of medicine and the development of pharmaceutical preparations; industrial analysis and research services in the field of development of pharmaceutical preparations, and in the field of identification of drug candidates; drug discovery services; basic research and clinical research, hereunder in the field of medicine and vaccine development; development of medical treatments related to rare and genetic diseases; development of medical treatments related to neurodegenerative diseases; development of medical treatments related to neuromuscular disorders; development of medical treatments that strengthen neuromuscular transmission and muscle function in patients with neuromuscular disorders; development of medical treatments for acute hospital care.
Owner
- NMD Pharma A/S, DK
Prosecution history
- 12 Mar 2026 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 12 Mar 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 12 Mar 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 12 Mar 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 12 Mar 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 12 Feb 2026 — REFUSAL PROCESSED BY IB
- 19 Jan 2026 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 18 Jan 2026 — REFUSAL PROCESSED BY MPU
- 04 Dec 2025 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 03 Dec 2025 — NON-FINAL ACTION WRITTEN
- 03 Dec 2025 — ASSIGNED TO EXAMINER
- 10 Nov 2025 — APPLICATION FILING RECEIPT MAILED
- 10 Nov 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 08 Nov 2025 — LIMITATION FROM ORIGINAL APPLICATION ENTERED
- 04 Sept 2025 — SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB